Maximizing ROI for Healthcare Organizations Through a Cost-Efficient Approach to Genetic Testing
The secret to success in maximizing ROI lies in maximizing cost efficiency. As demand for genetic testing explodes, especially in fields such as oncology, neurology and obstetrics, special expertise is needed to avoid incorrect coding and billing, and to ensure that health care dollars are spent in the most efficient and clinically appropriate ways. This […]
How DNAimpact Revolutionizes Personalized Genetic Healthcare
InformedDNA’s new platform, DNAimpact™,offers employers and health plans the opportunity for a scalable, general population precision health program. Genomic risk assessment, especially for younger populations, can lead to personalized screening and surveillance protocols for common complex diseases allowing diagnosis at earlier more treatable stages. DNAimpact™ is revolutionizing the application of genomic insights to enhance patient care and improve outcomes for all, shaping the future of precision health.
Our Take: Helping Payors Harness Precision Healthcare Providers
Exciting trends in precision health are reshaping the medical landscape at both the primary and specialty care levels. Innovations and clinical management advancements are enabling more genetic insights than ever before – and that momentum will only increase in the years to come. Today, oncologists can identify targeted therapies for certain patients using only a […]
How Healthcare Providers Help Patients with Medication Safety This National Check your Meds Day 2023
In today’s healthcare environment, patients can and want to more fully participate in their care management. Yet they do expect their healthcare provider to always be one step ahead, especially when it comes to their safety and overall well-being — it needs to be your highest priority. What is National Check Your Meds Day? National […]
Choosing a Genetic Testing Lab: Six Essential Questions for Healthcare Providers
The National Institutes of Health warns that “most genetic tests today are not regulated, meaning that they go to market without any independent analysis to verify the claims of the seller.”
